Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
120 open access dissertations and theses found for:
if(Docetaxel)  »   Refine Search
1.
Physical Characterization of Vernix Caseosa: Implications for Biological Function
by Joseph, Wael R., Ph.D.  University of Cincinnati. 2002: 149 pages; 10857220.
4.
Understanding the unique pathways of IBC cell survival and motility
by Joglekar-Javadekar, Madhura, Ph.D.  University of Delaware. 2013: 194 pages; 3594930.
5.
An Ensemble Prognostic Model for Metastatic, Castrate-Resistant Prostate Cancer
by Vang, Yeeleng Scott, M.S.  University of California, Irvine. 2016: 53 pages; 10162542.
6.
Distinct modes of cell death induced by vincristine in primary adult acute lymphoblastic leukemia cells
by Rathi, Anisha, Ph.D.  University of Arkansas for Medical Sciences. 2016: 140 pages; 10124725.
7.
8.
New endonuclease inhibitors and their potential therapeutic applications
by Jang, Dae Song, Ph.D.  University of Arkansas for Medical Sciences. 2015: 184 pages; 3704023.
9.
Discovery and Delivery of Synergistic Chemotherapy Drug Combinations to Tumors
by Camacho, Kathryn Militar, Ph.D.  University of California, Santa Barbara. 2015: 184 pages; 10011378.
10.
Optimizing the Sequence of Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma
by Meador, Catherine Belle, Ph.D.  Vanderbilt University. 2015: 243 pages; 13835143.
11.
12.
Growth inhibitory dioxonaphthoimidazoliums related to YM155: Synthesis and mechanistic investigations
by Sherman, Ho Si Han, Ph.D.  National University of Singapore (Singapore). 2015: 212 pages; 10006013.
13.
Implementing consistent and uniform assessment of chemotherapy-induced peripheral neuropathy
by Hendrix, Carolyn, M.S.N.  California State University, Long Beach. 2011: 73 pages; 1504474.
14.
Development of novel agent, VN/124-1, for the treatment of advanced prostate cancer
by Bruno, Robert D., Ph.D.  University of Maryland, Baltimore. 2009: 122 pages; 3355103.
16.
Quantitative Approaches for Understanding and Minimizing Chemotherapy-Induced Peripheral Neuropathy
by Zang, Xiaowei, Ph.D.  Rutgers The State University of New Jersey, School of Graduate Studies. 2019: 198 pages; 13419825.
17.
The synergistic effect of anti-androgens and signal transduction inhibitors in prostate cancer progression
by Schayowitz, Adam B., Ph.D.  University of Maryland, Baltimore. 2008: 186 pages; 3304002.
18.
Mitochondrial regulation of intracellular oxygen
by Prior, Sara Elizabeth, Ph.D.  University of Arkansas for Medical Sciences. 2014: 127 pages; 3704059.
19.
Chemotherapy-related cognitive impairment: The breast cancer experience
by Myers, Jamie S., Ph.D.  University of Kansas. 2010: 156 pages; 3434774.
20.
Helical collagen mimetic peptides as nanorod drug carriers
by Shinde, Aparna B., M.S.  California State University, Long Beach. 2013: 99 pages; 1523044.
21.
Learn & Apply Paradigm to Inform Drug Development & Optimize Clinical Therapeutics in Oncology
by Mehrotra, Shailly, Ph.D.  University of Maryland, Baltimore. 2017: 365 pages; 10262392.
22.
Suramin as a Chemo- and Radio-sensitizer: Preclinical Translational Studies
by Xin, Yan, Ph.D.  The Ohio State University. 2006: 193 pages; 10835734.
23.
Identification of Cdk1 as the vinblastine activated Bcl -xL kinase
by Terrano, David, Ph.D.  University of Arkansas for Medical Sciences. 2009: 152 pages; 3371362.
24.
Hollow Nanoshells for Cancer Diagnostics and Therapy
by Sandoval, Sergio, Ph.D.  University of California, San Diego. 2012: 131 pages; 3544917.
25.
Bcl-2 proteins in cancer cell survival and mitotic death
by Eichhorn, Josh M., Ph.D.  University of Arkansas for Medical Sciences. 2013: 132 pages; 3610331.
26.
Mouse Models of Prostate Cancer Bone Metastasis: Therapies and Mechanisms
by Cunningham, David M., Ph.D.  Tulane University. 2018: 104 pages; 10787826.
28.
Integrative Bioinformatic and Experimental Investigation of the Mechanisms of Brain Metastatic Adaptation
by Schnepp, Patricia M., Ph.D.  University of Notre Dame. 2017: 1556 pages; 13836357.
29.
Drug discovery through combination of computational screening and design, chemical synthesis and biological evaluations
by Berger, William T., Ph.D.  State University of New York at Stony Brook. 2013: 349 pages; 3608125.
30.
EGFR Rearrangements as Oncogenic Drivers and Therapeutic Targets in Lung Cancer
by Gallant, Jean-Nicolas, Ph.D.  Vanderbilt University. 2017: 127 pages; 10753387.
1 - 30 of 120 displayed.
  1    2    3    4   Next >
Copyright © 2019 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest